In a 23‑year‑old woman on day 3 of a second 7‑day course of nitrofurantoin (Macrobid) for uncomplicated cystitis who develops fever and chills, now afebrile with borderline hypotension and tachycardia and a negative urine analysis, what is the appropriate next step in management?

Discontinue Nitrofurantoin and Evaluate for Drug-Induced Fever or Evolving Pyelonephritis

This patient requires immediate cessation of nitrofurantoin and urgent assessment for either drug-induced systemic inflammatory response or progression to pyelonephritis, despite the currently negative urinalysis.

Immediate Management Steps

Stop Nitrofurantoin Now

• Nitrofurantoin must be discontinued immediately because the constellation of fever (101°F overnight), chills, tachycardia (113 bpm), and borderline hypotension (107/68) on day 3 of a second course strongly suggests either an acute drug reaction or progression to upper-tract infection that nitrofurantoin cannot adequately treat. 1
• Acute pulmonary and systemic hypersensitivity reactions to nitrofurantoin commonly manifest within the first week of treatment with fever, chills, and systemic symptoms; these reactions are reversible with immediate drug cessation. 1, 2
• Nitrofurantoin-induced systemic inflammatory response syndrome has been documented in case reports, presenting with fever and systemic symptoms that mimic infection but are actually drug-mediated. 3

Obtain Blood Cultures and Repeat Urine Culture Immediately

• Draw blood cultures now before initiating any new antibiotic, because fever with tachycardia and relative hypotension raises concern for bacteremia from ascending pyelonephritis. 4
• Obtain a fresh urine culture with susceptibility testing even though the urgent-care urinalysis was negative, because the timing (day 3 of treatment) and clinical picture (fever, chills, systemic symptoms) mandate culture-directed therapy. 4
• The negative urinalysis does not exclude pyelonephritis or treatment failure; pyuria and bacteriuria can be transiently suppressed by ongoing antibiotic therapy while viable organisms persist. 4

Assess for Pyelonephritis

• Examine for costovertebral angle tenderness, flank pain, nausea, or vomiting—any of these findings confirm pyelonephritis and require immediate escalation to fluoroquinolone or parenteral cephalosporin therapy. 4
• Fever >38°C (which occurred overnight at 101°F/38.3°C) with chills is a cardinal feature of uncomplicated pyelonephritis in a young woman; the absence of pyuria at urgent care does not rule out upper-tract involvement. 4
• Nitrofurantoin and fosfomycin are contraindicated for pyelonephritis because they do not achieve adequate tissue concentrations in the renal parenchyma; their use is limited strictly to lower-tract cystitis. 4, 5

Antibiotic Selection Based on Clinical Scenario

If Pyelonephritis Is Confirmed or Suspected

• Initiate ciprofloxacin 500 mg orally twice daily for 7 days as the first-line oral regimen for uncomplicated pyelonephritis in a young woman with no known fluoroquinolone resistance. 4
• Alternatively, prescribe levofloxacin 750 mg orally once daily for 5 days if ciprofloxacin is unavailable or the patient prefers once-daily dosing. 4
• If the patient appears clinically unstable (persistent tachycardia, hypotension, or inability to tolerate oral intake), administer ceftriaxone 1 g intravenously as a single dose before transitioning to oral fluoroquinolone therapy. 4
• Perform renal ultrasound or CT imaging if fever persists beyond 72 hours of appropriate antibiotic therapy to exclude obstruction, renal calculi, or perinephric abscess. 4

If Drug Reaction Is More Likely (No Flank Pain, CVA Tenderness Absent)

• Observe off all antibiotics for 24–48 hours while awaiting blood and urine culture results, because nitrofurantoin-induced systemic reactions resolve dramatically once the drug is stopped. 1, 2, 3
• If cultures return positive or symptoms worsen, switch to trimethoprim-sulfamethoxazole 160/800 mg orally twice daily for 7 days (assuming local E. coli resistance <20% and no recent TMP-SMX exposure) or a fluoroquinolone for 7 days if TMP-SMX is unsuitable. 4, 5
• Do not restart nitrofurantoin even if cultures show a susceptible organism, because the patient has now experienced a systemic reaction on re-exposure. 1, 3

Why the Negative Urinalysis Does Not Change Management

• Antibiotic suppression can transiently clear pyuria and bacteriuria while failing to eradicate the infection, especially in cases of resistant organisms or inadequate tissue penetration. 4
• The patient's initial response (symptom resolution for 2 days) followed by acute systemic symptoms suggests either treatment failure with progression to pyelonephritis or a drug-induced reaction—both require culture data and antibiotic change. 4
• Menstruation does not cause fever, chills, tachycardia, or hypotension; these findings mandate infectious or drug-related evaluation. 4

Critical Pitfalls to Avoid

• Do not continue nitrofurantoin in the setting of fever and systemic symptoms, as this risks progression of unrecognized pyelonephritis or worsening drug toxicity. 4, 1
• Do not assume the negative urinalysis rules out infection; obtain cultures and treat based on clinical presentation (fever, chills, tachycardia) rather than a single point-of-care test. 4
• Do not use fosfomycin for suspected pyelonephritis; it lacks adequate renal tissue penetration and efficacy data for upper-tract infections. 4, 5
• Do not delay imaging if fever persists >72 hours on appropriate therapy, as this may indicate obstruction or abscess requiring drainage. 4

Algorithmic Summary

1. Stop nitrofurantoin immediately. 1, 3
2. Draw blood cultures and obtain fresh urine culture with susceptibility testing. 4
3. Examine for CVA tenderness, flank pain, nausea/vomiting:
   • If present → Diagnose pyelonephritis → Start ciprofloxacin 500 mg PO BID × 7 days (or levofloxacin 750 mg PO daily × 5 days). 4
   • If absent → Suspect drug reaction → Observe off antibiotics pending cultures. 1, 3
4. If cultures positive or symptoms worsen → Switch to TMP-SMX 160/800 mg PO BID × 7 days (if local resistance <20%) or fluoroquinolone × 7 days. 4, 5
5. If fever persists >72 hours on appropriate therapy → Obtain renal imaging (ultrasound or CT). 4